IOVA earnings date and last-quarter result: last quarter beat, P/E -5.62. Updated 2026-07-23.
Iovance Biotherapeutics (IOVA) Research Hub
Iovance Biotherapeutics (IOVA) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 13.78 USD (-2.20%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -5.62, market cap 1.85B. This hub links to the full technical, earnings and options research available for IOVA.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 13.78 USD (-2.20%) |
| 52-week range | 3.76 USD – 15.37 USD |
| Trend regime | Range |
| 14-day RSI | 56.7 (Bullish) |
| Trailing P/E | -5.62 |
| Market cap | 1.85B |
| Dividend yield | 0.00% |
Available research for IOVA
Covered Call on IOVA: how it works, illustrative setup around the real 13.78 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on IOVA: how it works, illustrative setup around the real 13.78 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on IOVA: how it works, illustrative setup around the real 13.78 USD price, max profit/loss, breakeven and when to use it. Educational.
IOVA technical analysis: range, last 13.78 USD, RSI 56.7, 52w range 3.76 USD–15.37 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is IOVA in?
Iovance Biotherapeutics (IOVA) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is IOVA in an uptrend or downtrend?
As of 2026-10-26, IOVA is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is IOVA's trailing P/E ratio?
IOVA's trailing P/E is -5.62, with a market cap of 1.85B. See the earnings research page for full valuation detail.